Through a comprehensive analysis of three independent variants located in the BRC repeats of BRCA2, our goals were to not only identify potentially pathogenic variants with important clinical implications for cancer risk in patients, but to also leverage deleterious variants to uncover the specific functions carried out by individual BRC repeats. The gene discussed is BRCA2; the disease is cancer.